Cited by 75Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryPharmacology and Nanomedicine Research

Applications of Plant-Derived Extracellular Vesicles in Medicine

Open access
Zhu, Yawen, Zhao, Junqi, Ding, Haoran, Qiu, Mengdi, Xue, Lingling, Ge, Dongxue, Wen, Gaolin, Ren, Haozhen +2 more·2024·MedComm

Abstract

Plant-derived extracellular vesicles (EVs) are promising therapeutic agents owing to their natural abundance, accessibility, and unique biological properties. This review provides a comprehensive exploration of the therapeutic potential of plant-derived EVs and emphasizes their anti-inflammatory, antimicrobial, and tumor-inhibitory effects. Here, we discussed the advancements in isolation and purification techniques, such as ultracentrifugation and size-exclusion chromatography, which are critical for maintaining the functional integrity of these nanovesicles. Next, we investigated the diverse administration routes of EVs and carefully weighed their respective advantages and challenges related to bioavailability and patient compliance. Moreover, we elucidated the multifaceted mechanisms of action of plant-derived EVs, including their roles in anti-inflammation, antioxidation, antitumor activity, and modulation of gut microbiota. We also discussed the impact of EVs on specific diseases such as cancer and inflammatory bowel disease, highlighting the importance of addressing current challenges related to production scalability, regulatory compliance, and immunogenicity. Finally, we proposed future research directions for optimizing EV extraction and developing targeted delivery systems. Through these efforts, we envision the seamless integration of plant-derived EVs into mainstream medicine, offering safe and potent therapeutic alternatives across various medical disciplines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mco2.741

Cites

227 of 227 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Plant-derived EVs can deliver bioactive cargo that can influence multiple skin health pathways simultaneously, including melanogenesis and skin extracellular matrix maintenance.

    “There has already been evidence in the literature on plant-derived EVs that indicates their ability to deliver bioactive cargo and cargo packaged within, which can influence multiple skin health pathways simultaneously, including melanogenesis and skin extracellular matrix maintenance [9,10,21].”

    From A 28-Day Pilot Study of the Effects on Facial Skin Hydration, Elasticity, and Texture of a Centella asiatica Extracellular Vesicle-Based Skin Care Formulation (2025) · cites this paper as [21]

    The Natural plant-derived EVs section describes delivery of active ingredients through skin and a multipathway therapeutic approach. The Subcutaneous injection section links plant-derived EVs to collagen synthesis and remodeling in skin wound repair, supporting the extracellular-matrix aspect. Neither section establishes an effect on melanogenesis or shows that the named skin pathways are influenced simultaneously. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Compared with conventional plant extracts, EVs offer unique advantages such as membrane-protected cargo stability, targeted uptake by recipient cells, and potential cross-kingdom regulation of gene expression.

    “Compared with conventional plant extracts, EVs offer unique advantages such as membrane-protected cargo stability, targeted uptake by recipient cells, and potential cross-kingdom regulation of gene expression [9,21].”

    From A 28-Day Pilot Study of the Effects on Facial Skin Hydration, Elasticity, and Texture of a Centella asiatica Extracellular Vesicle-Based Skin Care Formulation (2025) · cites this paper as [21]

    The Introduction says EVs’ stable lipid membranes protect bioactive cargo and describes their cell-membrane traversal and more targeted delivery. The Cancer therapy section reports plant EVs delivering miRNAs to mouse tumor cells, where they regulated a signaling pathway. The paper does not establish that these properties are advantages compared with conventional plant extracts. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Clinical and early human studies using animal- or human-origin exosomes have reported improvements in skin quality and wound repair through angiogenesis, collagen synthesis, and anti-inflammatory activities.

    “While clinical studies on plant-derived EVs are currently scant, clinical and earlyhuman studies using animal-or human-origin exosomes have reported improvements in skin quality and wound repair through angiogenesis, collagen synthesis, and antiinflammatory activities [21,23].”

    From A 28-Day Pilot Study of the Effects on Facial Skin Hydration, Elasticity, and Texture of a Centella asiatica Extracellular Vesicle-Based Skin Care Formulation (2025) · cites this paper as [21]

    The Therapeutic Potential in Specific Diseases section says clinical trials have predominantly focused on mammalian EVs. The Subcutaneous Injection section describes neovascularization, collagen synthesis, and inflammation modulation as advantages for skin wound repair, but discusses plant-derived EVs rather than reported outcomes from animal- or human-origin exosomes. Our copy does not substantiate the claimed improvements in skin quality or wound repair in clinical or early human studies. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [203]Zhu H, Chang M, Wang Q, Chen J, Liu D, He W. Identifying the potential of miRNAs in Houttuynia cordata‐derived exosome‐like nanoparticles against respiratory RNA viruses. Int J Nanomedicine. 2023; 18: 5983‐ 6000. 37901360 PMC10612503

Cited by

Sorted by citations

Authors
Zhu, Y., Zhao, J., Ding, H., Qiu, M., Xue, L., Ge, D., Wen, G., Ren, H., Li, P., & Wang, J.
Affiliations
  • Nanjing University of Chinese Medicine (CN)
  • Jiangsu Province Hospital (CN)
Corresponding author
  • Ren, Haozhen
  • Li, Peng
  • Wang, Jinglin
Venue
MedComm
Publisher
Wiley
Published
2024-09-20
Volume
5
Issue
10
Pages
e741-e741
ISSN
2688-2663 (ISSN-L)
OpenAlex
W4402688701
Cited by
75
References
227
Citations by year
2026: 44 · 2025: 29 · 2024: 2
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • MedComm (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (82270646, 82100664, 82070438)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
Keywords
plant-derived extracellular vesicles, extracellular vesicles, anti-inflammatory activity, antimicrobial activity, anticancer activity, antioxidant activity, gut microbiota modulation, inflammatory bowel disease, cancer therapy, route of administration, bioavailability, immunogenicity, targeted delivery systems, production scalability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review